Travasol 2.07 g (l-Alanine SOLUTION) 2.07 G

TRAVASOL 2.07 G is an intravenous solution containing L-Alanine, designed for nutritional support. This product by Baxter Corporation aids in replenishing essential amino acids for patients requiring parenteral nutrition.

Strength

2.07 G

Pack Size

3000

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TRAVASOL 2.07 G is primarily used for intravenous nutrition, supplying L-Alanine to support metabolic processes. It is often utilized in clinical settings where oral nutrition is insufficient or not feasible, helping to maintain overall health and recovery.

Side Effects

When administered intravenously, TRAVASOL 2.07 G provides essential amino acids directly into the bloodstream. This can help support protein synthesis and overall metabolic function, aiding in recovery and maintaining nutritional balance.

Precautions & Warnings

TRAVASOL 2.07 G should be administered under medical supervision to ensure proper dosage and compatibility with the patient's condition. It is important to follow sterile procedures when handling the solution to prevent contamination.

Avoid Interactions

TRAVASOL 2.07 G may interact with other medications or supplements being administered intravenously. It is crucial to consult healthcare professionals to avoid potential interactions and ensure safe concurrent use with other treatments.

Frequently Asked Questions

TRAVASOL 2.07 G is used for intravenous nutrition, providing L-Alanine to support metabolic processes in patients who cannot consume nutrients orally.

TRAVASOL 2.07 G is administered intravenously, typically in a clinical setting under medical supervision.

TRAVASOL 2.07 G provides essential amino acids directly into the bloodstream, supporting protein synthesis and overall metabolic function.

TRAVASOL 2.07 G should be administered under medical supervision to ensure proper dosage and to prevent contamination.

TRAVASOL 2.07 G may interact with other medications or supplements being administered intravenously, so it is important to consult healthcare professionals.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.